Le produit a bien été ajouté au panier.

discount label
H-SLLMWITQV^-OH
Vue en 3D

Biosynth logo

H-SLLMWITQV^-OH

Ref. 3D-PP46378

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le lundi 28 octobre 2024

Informations sur le produit

Nom :
H-SLLMWITQV^-OH
Synonymes :
  • NH2-Ser-Leu-Leu-Met-Trp-Ile-Thr-Gln-Val^-OH
Description :

Peptide H-SLLMWITQV^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLLMWITQV^-OH include the following: Position-Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T-Cell Responses X He , S Zhou , B Quinn, WC Huang - Advanced , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202103023 Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2. 1 binding affinity and S Bownds, P Tong-On, SA Rosenberg - Journal of , 2001 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2001/01000/Induction_of_Tumor_Reactive_Cytotoxic.1.aspx/1000 Backbone modifications of HLA-A2-restricted antigens induce diverse binding and T cell activation outcomes R Gibadullin , CJ Randall, J Sidney - Journal of the , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jacs.1c00016 An isolated TCR alphabeta restricted by HLA-A* 02: 01/CT37 peptide Redirecting CD8+ T cells to kill and secrete IFN-γ in response to lung adenocarcinoma cell lines PO Flores-Villanueva, M Ganachari, H Guio - The Journal of , 2018 - journals.aai.orghttps://journals.aai.org/jimmunol/article/200/8/2965/106829 Quantifying and Imaging P Vyas, JL Chen , V Cerundolo, BK Karbach, E Jager - J Immunol, 2006 - academia.eduhttps://www.academia.edu/download/68505824/7308.full.pdf Preparation of peptide-MHC and T-cell receptor dextramers by biotinylated dextran doping MT Bethune , B Comin-Anduix, YHH Fu, A Ribas - , 2018 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2144/000114525 Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors MA Purbhoo, DH Sutton, JE Brewer - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/176/12/7308/7464 SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly M Fairhead , G Veggiani , M Lever, J Yan - Journal of the , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja505584f Structural and kinetic basis for heightened immunogenicity of T cell vaccines JL Chen , G Stewart-Jones, G Bossi, NM Lissin - The Journal of , 2005 - rupress.orghttps://rupress.org/jem/article-abstract/201/8/1243/52591 Ca2+ Release from the Endoplasmic Reticulum of NY-ESO-1-Specific T Cells Is Modulated by the Affinity of TCR and by the Use of the CD8 Coreceptor JL Chen , AJ Morgan, G Stewart-Jones - The journal of , 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/4/1829/38714 Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation J Brunnberg, M Barends - Proceedings of the , 2024 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2321600121 Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules GF Papadaki , O Ani, TJ Florio, MC Young - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1116906/full Rational development of high-affinity T-cell receptor-like antibodies G Stewart-Jones, A Wadle - Proceedings of the , 2009 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0901425106 and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide E Shenderov , M Kandasamy, U Gileadi - for immunotherapy of , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183295/ Synthesis and evaluation of novel TLR2 agonists as potential adjuvants for cancer vaccines BL Lu, GM Williams, DJ Verdon - Journal of Medicinal , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.9b01044 TCR fingerprinting and off-target peptide identification AR Karapetyan, C Chaipan, K Winkelbach - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.02501/full Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor A Varela-Rohena, PE Molloy, SM Dunn, Y Li - Nature medicine, 2008 - nature.comhttps://www.nature.com/articles/nm.1779 T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters A Brodovitch, E Shenderov , V Cerundolo - European journal of , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201445214

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP46378 H-SLLMWITQV^-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".